These insights enhance the understanding of mTOR pathway involvement in TSC‐related epilepsy and underscore the potential of targeting mTORC1, as well as epigenetic factors like NEAT1, for more effective therapeutic strategies. The gene discussed is NEAT1; the disease is epilepsy.